4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000138
Chief Scientific Officer acquired 14,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jewell Christopher M Chief Scientific Officer | 2024-11-20 | Option exercise | +14,000 | $3.23 | $45,220 | 39,940 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jewell Christopher M Chief Scientific Officer | 2024-11-20 | Option exercise · Stock Option (Right to Buy) | −14,000 | 76,432 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1732233005.xml…